A Phase II Study of Induction Consolidation and Maintenance Approach for Patients With Advanced Pancreatic Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Fluorouracil; Folinic acid; Gemcitabine; Irinotecan; Metformin; Oxaliplatin; Paclitaxel
- Indications Pancreatic cancer
- Focus Biomarker; Therapeutic Use
- 18 Aug 2016 Biomarkers information updated
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 30 Apr 2013 Planned end date changed from 1 Jan 2014 to 1 Aug 2014 as reported by ClinicalTrials.gov.